1.
Haematologica
; 107(2): 541-543, 2022 02 01.
Article
in English
| MEDLINE | ID: covidwho-1674305
2.
EJHaem
; 3(1): 215-217, 2022 Feb.
Article
in English
| MEDLINE | ID: covidwho-1669503
ABSTRACT
During the COVID-19 pandemic, access to health services has been considerably restricted and furthermore, patients have been reluctant to attend for routine monitoring, and this may have had a negative impact in the management of patients affected with haematological disorders. Sudden blast crisis in chronic myeloid leukaemia is categorized as a rapid onset of blastic phase, after a documented 'optimal' response to tyrosine kinase inhibitor (TKI) therapy and within 3 months of a normal complete blood count. Herein, we describe a case of patient who developed sudden blast crisis after TKI while in treatment-free remission.
3.
Cancer Cell
; 39(11): 1448-1449, 2021 11 08.
Article
in English
| MEDLINE | ID: covidwho-1611646
Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Immunity, Cellular/drug effects , Immunization Schedule , Immunogenicity, Vaccine , SARS-CoV-2/drug effects , Spike Glycoprotein, Coronavirus/immunology , Stem Cell Transplantation , T-Lymphocytes/drug effects , Adult , Aged , Antibodies, Viral/blood , BNT162 Vaccine , COVID-19/immunology , COVID-19/virology , ChAdOx1 nCoV-19 , Cytokines/blood , Female , Humans , Immunoglobulin G/blood , Lymphocyte Activation/drug effects , Male , Middle Aged , SARS-CoV-2/immunology , SARS-CoV-2/pathogenicity , T-Lymphocytes/immunology , T-Lymphocytes/virology , Time Factors , Transplantation, Homologous , Treatment Outcome , Vaccination
4.
Cancer Cell
; 39(12): 1654, 2021 Dec 13.
Article
in English
| MEDLINE | ID: covidwho-1588172
5.
Br J Haematol
; 190(5): e279-e282, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-593577